Bethesda, MD, June 18, 2013: The Association for Molecular Pathology is proud to announce it will join the Federation of American Societies for Experimental Biology (FASEB) on July 1, 2013. The FASEB Board approved AMP's application for membership on June 3, 2013.
The 26 constituent societies of FASEB represent more than 100,000 individuals and share a common vision for the advancement of research and education in biological and biomedical sciences. "Basic biomedical and translational research is more important now than ever," said Jennifer L. Hunt, MD, MEd, AMP President, "being a member of FASEB will enable AMP's voice to be even stronger."
AMP's 2,000+ members represent a unique and vitally important cross-section of specialties and subspecialties in the molecular pathology and diagnostic environment. "We are proud to have them as members," said FASEB President, Judith Bond, PhD, "We welcome the addition of their perspectives to our advocacy efforts and look forward to working closely with them on critically important research issues."
ABOUT AMP: The Association for Molecular Pathology (AMP) is an international medical professional association dedicated to the advancement, practice, and science of clinical molecular laboratory medicine and translational research based on the applications of molecular biology, genetics, and genomics. For more information, please visit http://www.amp.org.
ABOUT FASEB: The Federation of American Societies for Experimental Biology is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Its mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to its member societies and collaborative advocacy.
Mary Steele Williams
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.